These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats. Rota R, Chiavaroli C, Garay RP, Hannaert P. Eur J Pharmacol; 2004 Jul 14; 495(2-3):217-24. PubMed ID: 15249173 [Abstract] [Full Text] [Related]
4. The effect of calcium dobesilate on nonproliferative diabetic retinopathy: a controlled study. Stamper RL, Smith ME, Aronson SB, Cavender JC, Cleasby GW, Fung WE, Becker B. Ophthalmology; 1978 Jun 14; 85(6):594-606. PubMed ID: 353623 [Abstract] [Full Text] [Related]
5. Effect of calcium dobesilate on occurrence of diabetic macular oedema (CALDIRET study): randomised, double-blind, placebo-controlled, multicentre trial. Haritoglou C, Gerss J, Sauerland C, Kampik A, Ulbig MW, CALDIRET study group. Lancet; 2009 Apr 18; 373(9672):1364-71. PubMed ID: 19376452 [Abstract] [Full Text] [Related]
6. Treatment of blood hyperviscosity with calcium dobesilate in patients with diabetic retinopathy. Benarroch IS, Brodsky M, Rubinstein A, Viggiano C, Salama EA. Ophthalmic Res; 1985 Apr 18; 17(3):131-8. PubMed ID: 4011126 [Abstract] [Full Text] [Related]
7. Vitreous fluorophotometry and changes in blood-retinal barrier permeability induced by bendazac lysine. Nuzzi G, Venturini I, De Gregorio M, Arsenio L, Maraini G. Acta Ophthalmol Scand; 1997 Feb 18; 75(1):41-3. PubMed ID: 9088399 [Abstract] [Full Text] [Related]
9. Assessment of calcium dobesilate in diabetic retinopathy. A double-blind clinical investigation. Salama Benarroch I, Nano H, Pérez H, Elizalde F, Bisceglia H, Salama A. Ophthalmologica; 1977 Feb 18; 174(1):47-51. PubMed ID: 322009 [Abstract] [Full Text] [Related]
10. Antihistamines reduce blood-retinal barrier permeability in type I (insulin-dependent) diabetic patients with nonproliferative retinopathy. A pilot study. Gardner TW, Eller AW, Friberg TR, D'Antonio JA, Hollis TM. Retina; 1995 Feb 18; 15(2):134-40. PubMed ID: 7624601 [Abstract] [Full Text] [Related]
11. The value of calcium dobesilate in the treatment of diabetic retinopathy. A controlled clinical trial. Larsen HW, Sander E, Hoppe R. Diabetologia; 1977 Apr 18; 13(2):105-9. PubMed ID: 323093 [Abstract] [Full Text] [Related]
13. [Effect of calcium dobesilate on blood hyperviscosity]. Fortschr Med; 1979 Mar 08; 97(9):422. PubMed ID: 428880 [No Abstract] [Full Text] [Related]
14. Effect of calcium dobesilate on blood viscosity in diabetic microangiopathy. A review. Barras JP, Michal M. Vasa; 1986 Mar 08; 15(3):200-5. PubMed ID: 3532608 [No Abstract] [Full Text] [Related]
15. Effect of sorbinil on blood-retinal barrier in early diabetic retinopathy. Cunha-Vaz JG, Mota CC, Leite EC, Abreu JR, Ruas MA. Diabetes; 1986 May 08; 35(5):574-8. PubMed ID: 3514333 [Abstract] [Full Text] [Related]
16. Effect of cyclospasmol on early diabetic retinopathy. Mota MC, Leite E, Ruas MA, Verjans HL, Blakemore CB, Cunha-Vaz JG. Int Ophthalmol; 1987 Feb 08; 10(1):3-9. PubMed ID: 3549595 [Abstract] [Full Text] [Related]